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In 2003, Acanthamoeba polyphaga mimivirus (APMV) was first described and began to impact researchers around
the world, due to its structural and genetic complexity. This virus founded the family Mimiviridae. In recent years,
several new giant viruses have been isolated from different environments and specimens. Giant virus research is in
its initial phase and information that may arise in the coming years may change current conceptions of life,
diversity and evolution. Thus, this review aims to condense the studies conducted so far about the features and
peculiarities of APMV, from its discovery to its clinical relevance.
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Viruses are remarkable organisms that have always
attracted scientific interest. The study of unique viral
features has been a wellspring of discovery that helped
establish the foundations of molecular biology and led
to in-depth evolutionary studies [1-3]. In this context,
giant viruses have recently emerged as a fascinating line
of research, raising important questions regarding evo-
lution and their relationships with their hosts [4-10].
Although giant viruses offer deep ecological and clinical
importance, the Mimiviridae group deserves special em-
phasis; they have been the subject of intense research in re-
cent years, which has generated much relevant information
[4-8,11-14]. Acanthamoeba polyphaga mimivirus (APMV)
was the first known mimivirus, isolated from an amoebal
co-culture present in a water sample collected from a cool-
ing tower of a hospital in England. Its characterization re-
vealed surprising characteristics: it was a DNA virus with a
diameter of approximately 700 nm and a genome of ap-
proximately 1,2 Mb, making it the largest known virus up* Correspondence: jonatas.abrahao@gmail.com
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unless otherwise stated.to then [5]. Five years later, a similar virus was isolated in
amoeba from the water of a cooling tower in Paris, and
since then several dozen giant viruses have been isolated
from many different environments and specimens
[11,15-19]. Data obtained from these viruses provoked
scientific discussions regarding the nature and bio-
logical dynamics of viruses, and the intriguing features
Mimivirus have challenged virologists and evolutionists
alike. The potential existence of many other interesting
and unusual unknown viruses in the biosphere makes
us realize that the discovery and characterization of
giant viruses is in its initial phase and that there is still
much to be learned by studying these organisms. Re-
cently, the discovery of Pandoravirus (1 μm in length
and with a genome fo 2.8 Mb) and of Pithovirus siberi-
cum (1.5 μm in length and a surprisingly smaller gen-
ome of 600 kb) brought even more attention to the
prospection and study of giant viruses [19,20].Discovery and taxonomy
In 1992, a pneumonia outbreak occurred in a Bradford hos-
pital (England), and water samples from a cooling tower
that contained free-living amoebae were investigated to de-
termine the etiological agent of the pneumonia outbreak
[5]. At that time, Gram-positive cocci that were visualized
by light microscopy inside Acanthamoeba polyphaga cellsl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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microorganism and amplify its 16S rDNA failed. Moreover,
treatment of amoeba cultures with antibiotics to inhibit
growth of this microorganism was also unsuccessful, which
led doubt whether it was indeed a bacteria [5]. After a hia-
tus of a few years, this organism was the subject of new
studies at the Rickettsia Unit at the School of Medicine
(Marseille, France) in the early 2000s. After a new series of
unsuccessful characterization attempts, electron micros-
copy of Bradfordcoccus-infected Acanthamoeba polyphaga
cells revealed icosahedral-like particles with an astonishing
750 nm diameter size [5]. In addition to this virus-like
morphology, analysis of the replication curve of this organ-
ism in amoeba cells revealed an eclipse phase, which is an
almost universal feature among viruses. Finally, when the
complete sequencing and analysis of its genome was fin-
ished, it became evident that this peculiar organism clus-
tered with other giant viruses and not with bacteria [5].
This new virus was then called Acanthamoeba polyphaga
mimivirus (APMV), due its ability to infect the free-living
amoebae Acanthamoeba polyphaga sp. and mimic a mi-
crobe. APMV, also known as mimivirus, had the largest
viral genome known up to then, reaching approximately
1.2 Mb. Its characteristics were so different from other vi-
ruses that it was not possible to include it into any known
viral family, so the Mimiviridae family was created [5].
APMV became the first member of the Mimiviridae family,
Mimivirus genus, and its prototype.
Few years before the discovery of APMV, the genomic
content of known giant viruses that replicate partly or
entirely in the cytoplasm of eukaryotic cells (members
from Poxviridae, Asfarviridae, Phycodnaviridae, Ascovir-
idae and Iridoviridae families) was analyzed in depth.
Several common, and supposedly essential, genes were
identified, and it was suggested that the origin of these
four viral families was monophyletic [21-26]. Other
common characteristics, such as a large double-stranded
DNA genome, the relative independence of their host
transcription machinery, and a replication cycle that oc-
curs at least partially into the cytoplasm with the forma-
tion of inclusion bodies or viral factories, were the basis
for the generic name of these viral families: the nucleo-
cytoplasmic large DNA viruses (NCLDVs) [22-26]. Be-
cause viruses from the Mimiviridae family also share
these characteristics, they were added to the NCLDV
group as well.
After APMV was described, interest in giant viruses grew,
several other giant viruses were isolated, and the Mimiviri-
dae family was expanded. Currently, the Mimiviridae
family contains two genera according to the International
Committee on Taxonomy of Viruses (ICTV): Mimivirus,
with APMV as its only member, and Cafeteriavirus, with
Cafeteria roenbergensis virus as its only member (www.ict-
vonline.org). With the increasing number of new giant virusisolates and hypothetical species, a new viral order has been
proposed [27]. The putative Megavirales order contains the
Mimiviridae family and other NCLDVs, including the
newly proposed Marseilleviridae family [28], whose found-
ing member is Marseillevirus, another giant virus, smaller
than Mimivirus, that infects amoeba isolated from cooling
tower water in 2008 [18]. Mimivirus and Marseillevirus
have been primarily linked to other NCLDVs, based on a
set of ≈ 50 conserved core genes shared by all or by a ma-
jority of these large and giant viruses [29]. All these viruses
were shown to compose a monophyletic group [21]. Nucleo
cytoplasmic virus orthologous groups (NCVOGs) were de-
fined among these viruses, including 177 proteins present
in > 1 NCLDV family and five common to all viruses [30].
The discovery of new isolates of mimiviruses of
amoeba revealed the existence of three different lineages
(A, B and C). Lineage A of the Mimivirus genus contains
the best known mimivirus isolates, such as the APMV
species [5]. Mimivirus lineage B is represented by
Acanthamoeba polyphaga moumouvirus, which was iso-
lated from a water sample in February, 2008; genetic
analysis revealed differences that placed this virus into
the B lineage [15]. The first extensively described mem-
ber of lineage C was Megavirus chilensis, isolated from a
water sample collected off the coast of Chile [13]. Other
previously described mimiviruses, including Courdo7,
Courdo11, Terra1 and Montpellier, were also included in
lineage C [31]. Other viruses, including some that are
distantly related, have been obtained from environmen-
tal and clinical samples [32,33], and in the next years it
will likely be possible to present an extensive depiction
of the putative viral isolates, strains and species.
Amoebas as the main host of giant viruses
As mentioned above, the first mimivirus isolate was
discovered from studies of the pathogenic microorganisms
associated with amoebae (MPAAs) that were linked to noso-
comial pneumonia [5]. Free-living amoebae of the genus
Acanthamoeba belong to the Protist kingdom and can be
part of the normal microbiota of some animals, including
humans [34]. Amoebas from this genus are considered ubi-
quitous and have been isolated from various environments,
including soil, air, aquatic environments, sewage treatment
systems, contact lenses, hospital environments, and ventila-
tion and air conditioning systems [34-36]. Several studies
show that amoebas of this genus are very stable after treat-
ment with disinfectants and are highly resistant to extremes
of pH and temperature [34-37].
Free-living amoebae can cause severe and chronic
diseases by themselves, such as granulomatous amoebic en-
cephalitis, cutaneous acanthamoebiasis, amoebic keratitis
and primary amoebic meningoencephalitis [38]. They can
also carry other MPAAs that cause disease [39-41]. For ex-
ample, microorganisms of the Legionella, Parachlamydia
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causative agents of pneumonia, most of which is associated
with many cases of nosocomial lung infection [37,42,43].
Even after being phagocytosed, some MPAAs are able to
persist in the amoeba intracellular environment, and often
manage to multiply numerously [5]. Studies have described
amoebae isolation from many health institutions, revealing
the presence of free living amoebae on hospital floors and
objects, in intensive care units (ICUs), operating rooms,
nurseries, kitchens, emergency rooms and infectious dis-
ease wards, showing that the free living amoebas may serve
as potential platforms for amplification of pathogenic
MPAAS in these environments [40-43]. The attention given
to free living amoebas in recent years, together with the iso-
lation and characterization of mimiviruses in amoebal
samples from a cooling tower during an outbreak of pneu-
monia, add more importance to the role of mimiviruses as
MPAAs.
Up to now, amoebae of the Acanthamoeba genus are
the only confirmed APMV hosts; the virus was originally
isolated from A. polyphaga, but now is also being culti-
vated in the laboratory in A. castelannii, A. griffin and A.
lenticulata [5,44]. However, there is increasing evidence
that these viruses have a broader host range. Some stud-
ies have indicated sponges and corals as potential hosts
of mimivirus [44]. Khan (2007) described a productive
APMV infection in mice after intracardiac infection [45].
The ability of APMV to enter and replicate inside hu-
man phagocytic cells and peripheral blood mononuclear
cells in vitro has been reported [39]. These reports, to-
gether with the human blood isolation of the marseille-
virus, another giant virus of amoeba belonging to a
different family, suggests that vertebrates may also be
hosts of these viruses [46]. The mimivirus genome has
been detected in monkeys and bovines, supporting these
findings [47,48]. Recently, it has been shown that APMV
is able to interact with the human interferon system, a
strong clue that both species share an evolutionary his-
tory [49]. It appears that APMV’s ability to enter cells by
phagocytosis without identified specific cell receptors,
together with its large genome that confers a powerful
array of non-essential genes, permits APMV to exploit a
larger host range than initially believed [39,49]. Lastly, as
described in this review, there is ample evidence associ-
ating APMV and other mimiviruses with humans, espe-
cially regarding pneumonia cases [50-57].
Viral particle structure, genome and gene
expression
The remarkable size of mimiviruses and their peculiar
features make them unique among viruses. First of all,
their enormous size of approximately 700 nm lets them
be retained on 0,2 μm filters [5] (Figure 1-A to D).
APMV particles do not have an outer envelope, butfibers of approximately 120 nm can be associated with
the capsid [58,59] (Figure 1-A and B). These fibers, still
under investigation, may be involved in viral adsorption
to substrates. APMV encodes enzymes capable of syn-
thesizing polysaccharide complexes found in bacterial
lipopolysaccharide (LPS) and/or peptidoglycan [60-63].
These polysaccharides form the viral particle’s outer
layer, in which the fibers are embedded, and they
may also serve as a phagocytosis stimulus [58-63].
APMV has a pseudo-icosahedral symmetry, with a com-
plex pentagonal face region named stargate [60,63]. This
stargate form is a star-shaped projection from which the
viral genome is released, and it can be important during
early stages of the viral replication cycle [60,61,63,64]
(Figure 2).
The particle also contains internal membranes surround-
ing the genome, likely acquired from endoplasmic
reticulum [62] (Figure 1-A and B). The number of lipid
membranes inside mimivirus particles is still under debate
and investigation. At least three protein layers surround the
internal membrane, and the fibrils are projected from the
external layer in a tussock-like organization [62] (Figure 1-
B). Inside the APMV membrane, a core wall envelops the
viral DNA [62,63]. Some authors conjecture that APMV’s
unique particle structure may reflect horizontal gene trans-
fer (HGT), especially amongst organisms that share the
intracellular environment of amoeba, though adaptative
convergence should also be considered. The APMV gen-
ome is found in association with a fibrous matrix, resem-
bling the structure of most eukaryotic genomes; the
genome release by the stargate mechanism is similar to
genome releases in certain bacteriophages, and the peptido-
glycan matrix surrounding the external fibers is similar to
that found in certain bacteria [63].
This large and complex particle structure seems to be
vital for viral stability and genome integrity under ad-
verse environmental conditions [65-67]. The APMV gen-
ome consists of a double-stranded DNA molecule of
approximately 1,2 Mb that encodes approximately 1000
proteins, many of them still uncharacterized or having
functions never observed before in other viruses [5,68].
Four main groups of ORFs can be delineated in the
APMV genome: (i) Megavirales core genes; (ii) genes in-
volved in lateral gene transfer; (iii) duplicated genes; and
(iv) ORFans [69]. Some APMV encoded proteins are in-
volved in protein translation, DNA repair, cell motility
and membrane biogenesis [68-72]. Many of these pro-
teins are likely non-essential for viral replication, but
may possibly increase viral fitness. Some APMV genomic
sequences exhibit little or no homology with any other
known nucleotide sequences in the current databases,
and thus are called ORFans [69-72]. The presence of
genes encoding proteins involved in protein translation,
such as the amino-acyl tRNA synthetase (aaRS) and
Figure 2 Mimivirus replication cycle in amoebas. (I) Phagocytosis. (II) Virus entry into a phagosome, followed by star-gate opening and viral
membrane fusion (III). (VI) Viral seed is released in the amoeba cytoplasm and gives start to an early viral factory (V). After few hours, the viral fac-
tory grows and orchestrates the morphogenesis (VI) of the viral progeny, which are released by cell lysis. At the right, transmission electron
microscopy of APMV at its different steps of the replication cycle.
Figure 1 Mimivirus particle visualized by different microscopy methods. Transmission electron microscopy of APMV showing the complete
particle (A) and a zoom (B), highlighting the fibrils (F), the capsid protein layers (PL), the internal membrane (IM), and the core wall (CW) that
protects the viral genome and early factors. (C) and (D) show mimivirus isolates under scanning and atomic force microscopy, respectively. Scale
in (D) represents the sample depth and size.
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pendence from their host cell machinery for genome
replication [73,74].
No previously described viral genomes have shown a
genetic arsenal that is able to encode elongation factors,
such as tRNA and aaRS; those viruses instead must dir-
ectly rely on host elongation factors. A substantial pro-
portion of the Mimivirus, and Marseillevirus, ORFs have
homologs in bacteria, archaea, eukaryotes or viruses.
The large amount of chimeric genes in these viral ge-
nomes may have resulted from acquisitions by lateral
gene transfer, implying sympatric bacteria and viruses
with an intra-amoebal lifestyle [69].
The genomes of APMV and other mimiviruses have a
high adenine-thymine (AT) content, with their most fre-
quent codons being AAA (lysine) and AAT (asparagine).
Both the codon and amino acid usages of mimiviruses
are highly dissimilar to those of their amoebal host,
Acanthamoeba castellanii, and instead are correlated
with the high adenine and thymine (AT) content of the
mimivirus genomes [73,75]. Additionally, it has been
demonstrated that the Leu(TAA)tRNA present in several
mimivirus genomes, and in multiple copies in some viral
genomes, may complement the amoebal tRNA pool and
may help accommodate the AT-rich viral codons [75];
remarkably, the genes most highly expressed at the be-
ginning of the mimivirus replicative cycle have a nucleo-
tide content more adapted to the codon usage in A.
castellanii. Recently, an interesting study evaluated gen-
omic alterations in APMV maintained for 150 successive
passages in an axenic amoebal culture in an allopatric
system. It was shown that the genome was reduced in
size and morphological changes occurred in the viral
particle [76]. In the allopatric system, there was no com-
petition with other intra-amoebal micro-organisms, in-
cluding bacteria and other viruses; nor were there major
sources for gene gain and replacement from those
micro-organisms. The passaged APMV had large dele-
tions towards the APMV genome extremities and gene
losses that were associated with: loss of fibers and their
glycosylation; decreased viral ability to associate with vir-
ophages; and decreased particle antigenicity, likely due
to fiber loss [76]. Excluding large deletions, 77% of the
APMV genes remained intact after 150 passages in
amoeba, 23% had variability and 10% were predicted to
have inactivated. A majority of these inactivated genes
had been previously described as weakly transcribed in
APMV, prior to the laboratory culture under allopatric
conditions [68,77]. In contrast, most of the genes highly
transcribed before this laboratory culture were not inac-
tivated. The major loss of weakly transcribed and weakly
expressed genes in allopatric conditions suggests that
the virus tends to lose or degrade its useless genes in a
Lamarckian evolutionary process [77]. The loss can alsobe explained by the fact that DNA repair is most com-
mon in actively transcribed regions, so it is expected that
genes exhibiting lower transcriptional levels undergo
more changes [76,77].
Viral replication cycle
Although APMV is also unique in its replication cycle,
there is a resemblance to the poxvirus replication cycle [78]
(Figure 2). It has been demonstrated that APMV enters
amoebas of the Acanthamoeba genus through phagocytosis
(Figure 2-I), and the initiation of the replication cycle is
marked by a typical eclipse phase, in which viral particles
are not viewed in the cell [5,39]. In the early stages of repli-
cation, phagocytosed viral particles can be detected within
phagosomes inside the host cell until the star-gate channels
in the viral capsids (Figure 2-II) open, which is followed by
membrane fusion (Figure 2-III) and release of viral seeds
containing the genomes into the cytoplasm of the host cell
(Figure 2-IV) [78]. DNA replication occurs exclusively in
the cytoplasm, although it cannot be considered totally in-
dependent of the host nucleus because nuclear factors re-
quired for replication might participate in the process. It
has been demonstrated that multiple vesicles start to appear
in the cytoplasm approximately 2 hours after infection
[5,78]. Their origins are unknown, but it is suspected that
they are derived from the nuclear membrane or endoplas-
mic reticulum, and these vesicles seem responsible for nu-
clear factor transportation to the viral factories [78,79].
Atomic microscopy of infected amoebas revealed that the
nuclear morphology does not change during the APMV in-
fection cycle [80]. Following uncoating, the genome stabi-
lized in viral seeds initiates the viral factories (Figure 2-V
factory in formation; 2-VI mature factory). In these factor-
ies, viral DNA undergoes replication and transcription, and
the DNA is prepared to be packaged in procapsids through
a non-vertex portal, a transient aperture centered at an
icosahedral face distal to the DNA delivery site, suggesting
a pathway reminiscent of DNA segregation in bacteria
[63,64,78,79].
The transcription occurs in a temporal manner: early,
intermediate and late stages [80]. Interestingly, it was
demonstrated that mimivirus gene promoters exhibit an
unprecedented conservation among all eukaryotes [80].
After the expression of late genes, there is an increase in
viral factories and structural proteins are synthesized,
initiating the process of viral morphogenesis, followed
by packaging of capsids with DNA (Figure 2-VI). During
morphogenesis, membrane generation is accompanied
by the assembly of icosahedral viral capsids, a process
involving the hypothetical major capsid protein L425
that acts as a scaffolding protein [33]. An assembly
model was proposed explaining how multiple mimivirus
progeny can be continuously and efficiently generated.
There is a high accumulation of virions in final stages of
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strated in an interesting study, that professional phago-
cytes such as vertebrate monocytes and macrophages
are permissive for APMV replication, becoming infected
via phagocytosis that leads to productive infections [39].
Ultrastructural analysis showed that protrusions were
formed around the entering virus, suggesting that
macropinocytosis or phagocytosis was involved in
APMV entry. Reorganization of the actin cytoskeleton
and activation of phosphatidylinositol 3-kinases were
required for APMV entry [39]. However, although it has
been shown that APMV is able to interfere with the IFN
system in vertebrate cells, further studies are necessary
to understand the mechanisms involved in viral replica-
tion in vertebrate phagocytes [49].
The role of giant viruses in aquatic ecosystems
The isolation of giant viruses from many different speci-
mens, ranging from environmental samples to unicellular
eukaryotic green algae and even vertebrates, reveals their
ubiquitous presence on this planet. To date, we have iso-
lated many giant viruses from aquatic environments in
Brazil, especially from urban lagoons and acidic rivers, sug-
gesting an association between a high degree of organic
matter and giant virus detection [81] (unpublished data).
However, discovery of mimiviruses raises questions about
their ecological and evolutionary roles, especially in oceans.
Carbon transfer and nutrient recycling are important bio-
geochemical processes that deeply involve marine zoo-
plankton and phytoplankton [82,83]. Viruses are key
regulators of these processes, due to their ability to infect
and kill these populations, but the full extent of their role is
still unknown [82,83]. The discovery of giant viruses in
fresh and salt water provoked intense debate about the
ecology of these viruses in aquatic systems, as well as their
roles in structuring protist populations and even in gene ex-
change. In recent studies, it became evident that giant vi-
ruses can infect host protists, as in the case of the Cafeteria
roenbergensis virus infecting marine unicellular chlorophyll
flagellates [84]. It was suggested that the APMV group also
contains closely related viruses capable of infecting phyto-
plankton, and these viruses groups phylogenetically with
certain viruses of unicellular and multicellular algae [85].
Metagenomic studies, conducted in 2005 during the Global
Ocean Sampling expedition in the Sargasso Sea, demon-
strated through phylogenetic analysis that DNA viruses that
are evolutionarily close to mimivirus exist in nature
[10,86,87].
Several mimivirus-like sequences were identified, suggest-
ing that these viruses are abundant in the marine environ-
ment. This key finding suggests that further studies of these
genomic sequences can reveal the diversity of these DNA
viruses and their possible roles in the evolution of eukary-
otes [86]. To a lesser extent but similar to the interaction ofphages and bacteria, prokaryotes that are lysed by the
multiplication of marine mimiviruses could result in in-
creased dissolved carbon and nutrients in surface waters,
which might reduce sedimentation, promote microbial
growth and impact local communities.
Giant viruses and the contribution to evolution
knowledge
Canonically, it is considered that the genomes of most
viruses do not contain sufficient information to support
their classification into a domain of life. However, with
the discovery of APMV and other giant viruses, this
topic is being debated [24,26,88]. Giant viruses have
genes that are common to the three classical Domains
of life: Archaea, Bacteria and Eukarya, including genes
involved in information storage and processing. For
some researchers, this phenomenon puts them in the
same definition of life that is assigned to those Domains
[26]. Some APMV genes are notable due their hypothet-
ical evolutionary importance. Recent studies have indi-
cated the existence of a host-independent glycosylation
system in APMV, likely acquired very early during evolu-
tion [89]. Collagen, one of the most abundant proteins
in living cells, is found in APMV and undergoes a new
type of glycosylation, showing for the first time that
post-translational collagen modifications are not re-
stricted to the canonical domains of life [90]. These re-
sults indicate that mimiviruses may have contributed to
the evolution of collagen biology [90]. Genes coding for
proteins involved in the replication and repair of DNA,
such as DNA polymerase B and topoisomerase II, and
genes for the thymidine synthetase enzymes involved in
the biosynthesis of DNA oligonucleotides, are typical of
eukaryotic cells but are also found in giant viruses [73].
A phylogeny based on these proteins results in an exclu-
sive clade for the giant viruses, distinct from Eukarya,
Bacteria and Archaea [26].
Analysis of the transcription factor II B, absent in Bac-
teria, suggests that it is highly conserved and forms a
clade as old as Eukarya and Archaea itself [88]. Analysis
of the aaRS genes reveals similarity between Mimiviri-
dae, Amoebazoa and Eukarya. It supports the possibility
that these genes may have been transferred from a viral
ancestor to amoebae, suggesting that these exchanges
are common [88]. However, this specific gene has been
described as involved in a lateral gene transfer. These in-
triguing results led some authors to question the com-
prehensiveness of phylogenetic trees based on analysis of
ribosomal RNA because they exclude viruses and do not
seem sufficient to represent all forms of life and to
propose a fourth domain of life based on phylogenetic
and phyletic analyses of informational genes [24,26,88].
The current classification, based on patterns of similarity
of ribosomal RNA, is a prejudiced approach because it
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not harbor ribosomal genes. However, the proposition of
a fourth Domain of life to accommodate giant viruses is
still much in debate. Some authors believe that the
fourth domain may be artifactual, due to compositional
heterogeneity and homoplasy, and the use of genes pos-
sibly acquired by the viruses from their eukaryotic hosts
by horizontal gene transfer (HGT) [88].
Virophages
The isolation of Acanthamoeba castellanii mamavirus
(ACMV) led to the discovery of one of the most intri-
guing and differentiating features of the Mimiviridae
family: its close association with other small viruses
called the Sputnik virus. Sputnik virus was first identified
as a satellite virus [11]. Its replication, associated with
the Mimivirus factories inside amoebas, resembled satel-
lite viruses that affect animals and plants. However,
Sputnik virus replication appears to impair the normal
morphogenesis and production of Mimivirus, a process
closer to true parasitism than to the previously known
satellite viruses. From a biological view, the infection
with Sputnik virus results in ~ 70% reduction of the cy-
topathic effect of the giant viruses in amoeba and leads
to formation of some atypical viral forms, in a way never
described for traditional satellite viruses [11,12]. This
discovery led to the creation of the term “virophage”,
which means a virus able to ‘infect’ other viruses [11,12].
Sputnik virus is an icosahedral virus 50 nm in diameter
and a genome of 18 kb, which contains a mosaic of
genes related to bacteriophages, other viruses and amoe-
bae. Its genome is circular double-stranded DNA that is
hypothetically able to encode 21 proteins, some of which
have no detectable homologues in current databases of
nucleotide sequences [11,12].
Recently, we have isolated Rio Negro virophage associ-
ated with Samba virus, an APMV strain from the Brazilian
Amazon [81]. Other described virophages are parasites of
the giant viruses (phycodnaviruses and mimiviruses) [32]
and might control the dynamics of Antarctic alga species.
Mavirus is a virophage that parasitizes the giant Cafeteria
roenbergensis virus [91]. On the basis of genetic homology,
Mavirus likely represents an evolutionary link between
double-stranded DNA viruses and Maverick/Polinton
eukaryotic DNA transposons [91]. It has been shown that
giant viruses may even have virophages inside their own
mobile genetic elements. A 2013 study of the mobilome of
Lentille virus revealed that a virophage, Sputnik 2, is part of
this genetic element [14]. It was observed by FISH that the
virus and its virophage replicate in the same viral factories
and are detected in the cytoplasm of the host cell, suggest-
ing that Sputnik 2 was integrated into the Lentille virus
genome [14]. This was confirmed by genome digestion of
these viruses, followed by Southern blotting and 2D gelanalysis. Lentille virus was sequenced on different plat-
forms, and a sequence related to Sputnik2 was integrated in
its genome, thus suggesting that Sputnik2 is a provirophage.
These analyses also revealed that Lentille virus (and a small
fraction of Sputnik2) contained an extrachromosomal DNA
rich in CG that was called a transpoviron (an equivalent of
transposon in viruses from our point of view), which can
undergo recombination with Sputnik2 and many other or-
ganisms [14]. Phylogenetic analysis of the virophages and
related genetic elements is compatible with the concept of
a network-like evolution in the virus world and emphasizes
multiple evolutionary connections between bona fide vi-
ruses and other classes of capsid-less mobile elements.
Thus, giant viruses appear to present a complex mobilome,
which could contribute to gene exchanges that are com-
mon in these viruses. Further investigation of these ele-
ments will possibly lead to new discoveries, including novel
classes of mobile elements, thanks to the diversity and
complexity of giant viruses and their virophages [92].
Clinical significance
Hospitalized patients are a risk group for nosocomial in-
fections, including those caused by amoeba-associated
pneumonia agents [54,93]. APMV is a putative pneumonia
agent and studies associating this virus with human pneu-
monia cases are still under investigation [51,54,55,94-97].
APMV genetic material (once) and antibodies against
APMV have been detected in samples from patients who
had pneumonia without any known cause (bacterial, viral
or fungal); these patients came from different locations
and were studied by different research groups, lending
strength to the possible role of APMV as a pneumonia
agent [54-57,98]. The genetic diversity among the Mimi-
viridae members needs to be considered when interpret-
ing negative PCR tests in several studies because the
diversity may have impaired detection of APMV-related
DNA [29]. An animal model for mimivirus pneumonia
studies has been proposed. When various routes of
infection were tested, the intracardiac infection route in-
duced pneumonia in C57/B6 mice [45]. Although this
model does not exactly simulate the hypothetical natural
route of mimivirus infection, it was possible to observe
histopathological evidence of acute pneumonia, isolate the
virus and detect antigens by indirect immunofluorescence
assay [45].
The first studies in which a giant virus was successfully
isolated from a human specimen were published in 2013
[50,52]. In a first study, a total of 196 samples from pa-
tients were collected in Tunisia between 2009 and 2010;
virus was detected by the formation of plaques in mono-
layers of amoeba grown on agar plates [52]. The isolated
virus (LBA111) was found in a sample obtained from a
72-year-old patient with pneumonia. Serology and real
time PCR confirmed the presence of a giant virus in this
Figure 3 Timeline highlighting some hallmarks of mimivirus and related topics. Interest on the subject “Mimivirus”, “Poxvirus”,
“Phycodnavirus” and “Asfarvirus” as a research terms in Google Search, over time. The incidence of the research for these subjects in Google
Search was obtained by the use of Google Trends tool (http://www.google.com/trends/). The graphics depict relative interest over time (%). The
values are in comparison to the highest number of searches at a given occasion (see “help” in Google Trends website). Google trends show
available data since 2004. A timeline was set in the bottom of the figure, highlighting some hallmarks of mimivirus and related topics.
Abrahão et al. Virology Journal 2014, 11:120 Page 8 of 12
http://www.virologyj.com/content/11/1/120sample. LBA111 has a similar morphology to other
mimiviruses, with a size of approximately 560 nm and a
genome of 1,23 Mb. Western blot analysis showed posi-
tive immunoreactivity of patient sera against specific
proteins of both APMV and LBA111 [52]. In another
study, Shan virus was isolated from a stool sample col-
lected from a Tunisian patient with pneumonia [50].
Metagenomic analysis of a human stool sample revealed
the presence of sequences similar to those of giant vi-
ruses. From these samples, a virus was isolated and
named Senegalvirus [53]. Its characteristics linked it to
the Marseilleviridae family, representing the first detec-
tion of a marseillevirus from a human sample [53].Figure 4 Cumulative number of publications relating to mimivirus an
2003 (http://www.ncbi.nlm.nih.gov/pubmed)”. (A) Cumulative number
researched on Pubmed page (http://www.ncbi.nlm.nih.gov/pubmed), dem
discovery in 2003. (B) Published “mimivirus”/”giant viruses” papers per yearAdditionally, a blood sample from an apparently healthy
donor revealed the presence of Marseillevirus-like DNA;
antigens from this virus were detected, it was visualized
by microscopy and it grew in human T cell lymphocytes
[46].
The potential clinical relevance of mimivirus can also be
analyzed by studies involving the host-virus relationship. In
2008, it was observed that APMV is internalized by profes-
sional phagocytic cells such as macrophages, but not by
non-phagocytic cells like fibroblasts, epithelial or neuronal
cells [39]. This suggests that these professional phagocytic
cells can be targets for APMV replication in humans. Ana-
lysis of ‘infected’ macrophages revealed that viral DNAd “mimivirus”/”giant viruses” over time since its discovery in
of publications relating to mimivirus over time. The subject was
onstrating the growing number of papers related to the virus since its
since 2003, also according to the Pubmed website.
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pathogenic for these cells [39]. Recently, a study investi-
gated whether human peripheral blood mononuclear cells
(PBMC) can recognize APMV presence by measuring IFN
induction; whether APMV can replicate in these cells; and
whether replication of the virus is affected by treatment of
cells with IFN type I [49]. The results showed that APMV
is able to replicate in human PBMC and induce type I IFN
in these cells and that it inhibits some IFN-stimulated genes
(ISG) by a mechanism that is independent of viroceptors
and STAT dephosphorylation [49]. It was also seen that
APMV is resistant to the antiviral action of IFN alpha2
(IFNA2), but is sensitive to the antiviral action of IFN beta
(IFNB1). These results not only confirm that APMV can in-
deed replicate in vertebrate phagocytes but also show that
it is recognized by the innate immune system and that it is
likely able to at least partially evade that system [49]. This
interaction is most likely the result of co-evolution between
APMV and vertebrate hosts, and it is strong evidence of an
ancestral relationship between these organisms [49]. Re-
cently, mouse exposure to mimivirus collagens was shown
to induce anti-collagen antibodies that also targeted mouse
collagen type II, and the exposure was associated with
T-cell reactivity to collagen and joint inflammation [99].
Furthermore, a serologic study found reactivities to the
mimivirus collagen protein L71 in 22% of rheumatoid arth-
ritis patients, compared to 6% of healthy-subjects. Thus,
while clinical studies involving mimivirus are still a growing
field, research over the past few years is strengthening the
idea that mimiviruses, which are broadly distribution in our
biosphere, not only have an environmental impact but are
also involved in human health.
Viral resistance to chemical and physical biocides
The probable importance of APMV as a human pathogen
in hospital environments has led to the need for investigat-
ing the virucidal activity of chemical biocides used for disin-
fection in hospitals. In a study performed in 2012, it was
shown that APMV is especially resistant to alcohols but is
sensitive to the action of active chlorine and glutaraldehyde,
and it is able to remain stable on inanimate surfaces for
30 days, even in the absence of organic matter; this high-
lights the need for best strategies to control this putative
pneumonia agent in hospital environments [69]. Amoebae,
the hosts of several giant viruses, may act as biological plat-
forms in the spread of pathogens such as Legionella, Para-
chlamydia, Mycobacterium and also APMV, representing a
public health concern. In 2013 we investigated the APMV
survival in certain adverse conditions when present in the
intracellular environment of A. castellanii [100]. It was
found that when APMV is inside an amoebal cell subjected
to UV irradiation, heat or exposure to different chemical
biocides, it remains more stable, showing that these hosts
can act like natural bunkers for APMV, increasing itsresistance to the viral agents used to disinfect hospital
environments [100]. In addition, Acanthamoeba spp. may
represent a training field for human pathogens, as several
micro-organisms resisting these amoebae were concur-
rently found to resist human macrophages [40].Giant viruses publication indicators
An indicator of the growth of related research fields con-
cerning giant viruses is the recent increase in the number
of publications about APMV and other giant viruses. In
2013, the number of papers related to these fields was 21-
fold greater than to the number of papers published in
2003, the year of APMV discovery (Figures 3 and 4). Inter-
est in APMV also increased in internet search tools such as
Google Search (Google Trends) over the years, with peaks
in 2004, 2006 and 2009 (Figure 3) that most likely are re-
lated to mimivirus research hallmarks, such as its discovery,
its association to virophages and studies describing APMV
as a putative pneumonia agent [5,11,57,73] (Figure 3). Cur-
rently, mimiviruses are the second group amongst NCLDVs
most searched in the Google platform, and, on some
occasions, even overcomes the well-known poxviruses
(Figure 3).Conclusions
As described, APMV and other giant viruses have emerged
as a fascinating line of research. Each discovery regarding
mimiviruses has overwhelmed scientists from different
areas of expertise, which may explain why so many out-
standing publications are multidisciplinary. The future of
mimivirus studies might go beyond the description of big-
ger and more complex viruses but also may contemplate
deep structural, genetic and evolutionary studies. With all
this knowledge, we expect it will be possible to understand
the exact role of mimiviruses in environmental dynamics
and their importance as etiological agents of pneumonia in
humans and other animals.
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